|CD1d–lipid-antigen recognition by the semi-invariant NKT T-cell receptor|
NA Borg, KS Wun, L Kjer-Nielsen, MCJ Wilce, DG Pellicci, R Koh, ...
Nature 448 (7149), 44-49, 2007
|Immune self-reactivity triggered by drug-modified HLA-peptide repertoire|
PT Illing, JP Vivian, NL Dudek, L Kostenko, Z Chen, M Bharadwaj, ...
Nature 486 (7404), 554-558, 2012
|Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers|
R Elkington, S Walker, T Crough, M Menzies, J Tellam, M Bharadwaj, ...
Journal of virology 77 (9), 5226-5240, 2003
|Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity|
D Chessman, L Kostenko, T Lethborg, AW Purcell, NA Williamson, ...
Immunity 28 (6), 822-832, 2008
|T cell allorecognition via molecular mimicry|
WA Macdonald, Z Chen, S Gras, JK Archbold, FE Tynan, CS Clements, ...
Immunity 31 (6), 897-908, 2009
|Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor|
R Reantragoon, L Kjer-Nielsen, O Patel, Z Chen, PT Illing, M Bhati, ...
Journal of Experimental Medicine 209 (4), 761-774, 2012
|Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion|
D Zernich, AW Purcell, WA Macdonald, L Kjer-Nielsen, LK Ely, N Laham, ...
Journal of Experimental Medicine 200 (1), 13-24, 2004
|Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex|
M Bharadwaj, P Illing, A Theodossis, AW Purcell, J Rossjohn, ...
Annual review of pharmacology and toxicology 52, 401-431, 2012
|High incidence of hepatitis C virus reinfection in a cohort of injecting drug users|
CK Aitken, J Lewis, SL Tracy, T Spelman, DS Bowden, M Bharadwaj, ...
Hepatology 48 (6), 1746-1752, 2008
|Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load|
SL Silins, MA Sherritt, JM Silleri, SM Cross, SL Elliott, M Bharadwaj, ...
Blood, The Journal of the American Society of Hematology 98 (13), 3739-3744, 2001
|Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma|
J Duraiswamy, M Sherritt, S Thomson, J Tellam, L Cooper, G Connolly, ...
Blood, The Journal of the American Society of Hematology 101 (8), 3150-3156, 2003
|Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis|
SL Elliott, A Suhrbier, JJ Miles, G Lawrence, SJ Pye, TT Le, ...
Journal of virology 82 (3), 1448-1457, 2008
|A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition|
L Kjer-Nielsen, NA Borg, DG Pellicci, T Beddoe, L Kostenko, CS Clements, ...
The Journal of experimental medicine 203 (3), 661-673, 2006
|Peptide-MHC class I tetrameric complexes display exquisite ligand specificity|
SR Burrows, N Kienzle, A Winterhalter, M Bharadwaj, JD Altman, ...
The Journal of Immunology 165 (11), 6229-6234, 2000
|Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy|
MA Sherritt, M Bharadwaj, JM Burrows, LE Morrison, SL Elliott, JE Davis, ...
Transplantation 75 (9), 1556-1560, 2003
|Induction of therapeutic T-cell responses to subdominant tumor-associated viral oncogene after immunization with replication-incompetent polyepitope adenovirus vaccine|
J Duraiswamy, M Bharadwaj, J Tellam, G Connolly, L Cooper, D Moss, ...
Cancer Research 64 (4), 1483-1489, 2004
|Nucleoprotein of influenza A virus is a major target of immunodominant CD8+ T‐cell responses|
E Grant, C Wu, KF Chan, S Eckle, M Bharadwaj, QM Zou, K Kedzierska, ...
Immunology and cell biology 91 (2), 184-194, 2013
|Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load|
B Cameron, M Bharadwaj, J Burrows, C Fazou, D Wakefield, I Hickie, ...
The Journal of infectious diseases 193 (5), 664-671, 2006
|Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia|
ER Miller, ME Hellard, S Bowden, M Bharadwaj, CK Aitken
Journal of infection 58 (5), 375-382, 2009
|Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse …|
J Duraiswamy, JM Burrows, M Bharadwaj, SR Burrows, L Cooper, ...
Journal of virology 77 (13), 7401-7410, 2003